Karen Chen
Medical · Abington, PANPI 1366112567
Payments from drug & device makers
Across 113 payments — averaging $30.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$909
- Alkermes, Inc.$397
- AstraZeneca$295
- Pfizer$225
- Lundbeck LLC$203
- Supernus Pharmaceuticals, Inc.$200
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,39398%
- Education$772%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $909 |
| Alkermes, Inc. | 6 | $397 |
| AstraZeneca | 10 | $295 |
| Pfizer | 12 | $225 |
| Lundbeck LLC | 9 | $203 |
| Supernus Pharmaceuticals, Inc. | 3 | $200 |
| Neurelis, Inc. | 2 | $136 |
| SK Life Science, Inc. | 2 | $129 |
| Livanova USA, Inc. | 1 | $104 |
| Johnson & Johnson | 2 | $102 |
| Neurocrine Biosciences, Inc. | 1 | $99 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $90 |
| Argenx US, Inc. | 3 | $79 |
| Vanda Pharmaceuticals Inc. | 3 | $59 |
| Corium, LLC | 2 | $54 |
| Impel Pharmaceuticals LLC | 3 | $51 |
| Ironshore Pharmaceuticals Inc. | 2 | $44 |
| Amgen | 2 | $44 |
| Bausch Health US, LLC | 2 | $43 |
| Springworks Therapeutics, Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| CSL Behring | 1 | $22 |
| EMD Serono, Inc. | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Eisai Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Tanabe Pharma America, Inc. | 1 | $15 |
| Biogen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,470 in reported general payments places this provider in the 85th percentile of 2,594 medical providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NuplazidPimavanserin Tartrate | 47 | $310,094 |
| CopaxoneGlatiramer Acetate | 32 | $189,997 |
| AustedoDeutetrabenazine | 15 | $129,907 |
| RexultiBrexpiprazole | 30 | $61,254 |
| BriviactBrivaracetam | 27 | $60,192 |
| Aimovig AutoinjectorErenumab-Aooe | 35 | $45,261 |
| Nurtec OdtRimegepant Sulfate | 13 | $26,746 |
| KeppraLevetiracetam | 11 | $19,655 |
| AmpyraDalfampridine | 12 | $18,696 |
| AptiomEslicarbazepine Acetate | 13 | $16,523 |
| Oxtellar XrOxcarbazepine | 11 | $14,639 |
| FycompaPerampanel | 11 | $13,956 |
| Lacosamide | 80 | $11,054 |
| Levetiracetam | 289 | $10,652 |
| LyricaPregabalin | 11 | $10,077 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $25 | $61,25430 claims |
| PfizerNurtec Odt, Lyrica | $225 | $36,82324 claims |
| Supernus Pharmaceuticals, Inc.Oxtellar Xr | $200 | $14,63911 claims |
| Eisai Inc.Fycompa | $15 | $13,95611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,594 medical providers in Pennsylvania.
Other medical in Abington
- Jacqueline KernaghanSpringfield$427K
- Drew SodaNew Hope$220K
- Angela KapalkoPhiladelphia$123K
- Linda PerryPhiladelphia$123K
- Cory DavidsonErie$119K
- Shelley SassamanTamaqua$90K
- Meghan HoffnerBethlehem$86K
- Thomas IacovoniDanville$72K
- Scott CoxWynnewood$66K
- Sarah SmithPhiladelphia$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.